Molecular analysis of the immune environment of neuroendocrine tumors and associations with clinical outcomes
Matthew H. Kulke, MD
Funded Research Projects
Developing novel treatments for NETs using CAR T-Cell Technology
Carl June, MD; Xianxin Hua, MD, PhD; David Metz, MD
Multifunctional nanomedicine for targeted carcinoid cancer therapy
Herbert Chen, MD
Implication of heterogeneous innate immune cells in pancreatic NET resistance
Gabriele Bergers, PhD
Identifying altered epigenetic states and drivers in intestinal carcinoid and pancreatic NETs
Bradley Bernstein, MD, PhD
Epigenomic analysis of intestinal neuroendocrine cells and the epigenetic basis of NETs
Ramesh Shivdasani, MD, PhD
Theranostics of NETs with somatostatin antagonists
Wolfgang Weber, MD, PhD; Diane Reidy-Lagunes, MD
Understanding the tumor suppressor activities of ATRX-DAXX through epigenomic profiling and animal models
Peter Lewis, PhD; C. David Allis, PhD
The mechanistic underpinnings of pancreatic NETs
Guillermina Lozano, PhD
Overcoming Resistance to mTOR Inhibition in pancreatic NETs
Eric Nakakura, MD, PhD